Abstract
Background Suicide among adolescents is a significant global public health concern. This study aimed to assess the prevalence and associated factors of suicidal ideation and attempts among adolescents attending care at St. Paul’s Hospital Millennium Medical College, Pediatrics Department, Addis Ababa, Ethiopia. Methods A hospital-based cross-sectional study was conducted, recruiting 317 participants for interviews using a proportional stratified sampling technique. The Composite International Diagnostic Interview (CIDI) was utilized to evaluate instances of suicide. The PHQ-9-(A) and an Oslo-3 social support instrument were used to assess depression and social support. Bivariate and multivariate binary logistic regressions were employed to identify factors associated with suicidal ideation and attempts. Statistical significance was indicated by a P-value <0.05, and the strength of association is presented as an adjusted odds ratio with a 95% confidence interval. Results The findings of this study revealed that the prevalence of suicidal ideation and suicide attempts were 12.6% and 6%, respectively. Among the respondents who had positive ideation, approximately 28% had thought about it at least once, 31.5% had thoughts at least two times, and 5% claimed they had contemplated committing suicide up to ten times in their lifetime. According to the multivariate analysis, being aged 15-19 years, having a widowed family status, a family history of mental illness, poor social support, and depression according to the PHQ-9 were significantly associated with suicidal ideation. Additionally, participants who had experienced a loss of a family member and those with depression had a significant risk of suicide attempts. Conclusion The results suggest that the magnitude of suicidal ideation and attempts is high, indicating a critical need for early suicide-focused regular screening for those on follow-up for other medical illnesses and linkage with mental health service providers.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Yes
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Not Applicable
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This research has been approved by the St. Paul's Hospital Millennium Medical College IRB Reference no. pm13/916, on 13/6/2013. the IRB file is attached with the main manuscript during submission. We have prospectively recruited human participants and collected data for the study using face to face interview using structured questionnaires. Participants provided informed and verbal assent. It was witnessed and documented in the data forms. We have obtained consent from parents or guardians.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Not Applicable
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Not Applicable
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Not Applicable
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.